Neurotherapeutics? is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.
The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.
Neurotherapeutics ? delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.
《Neurotherapeutics》是一本由SPRINGER出版商出版的专业医学期刊,该刊创刊于2004年,刊期Quarterly,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:临床神经病学 2区;神经科学 2区;药学 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖临床神经病学等领域,旨在及时、准确、全面地报道国内外临床神经病学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为6.088,平均审稿速度较慢,6-12周。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 | 2区 2区 2区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | NEUROSCIENCES | Q1 | 6.088 |
CLINICAL NEUROLOGY | Q1 | ||
PHARMACOLOGY & PHARMACY | Q1 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
6.088 | 100 | 21.55% | 65.06% | 未开放 | 较慢,6-12周 |